It has been proposed that either the Igf-2 gene or the Ii19 gene -but not both -can be expressed from a given chromosome.
Intrductlon
HI9 is an active RNA with unknown function which is extensively expressed during embryonic and foetal development (Pachnis et al., 1988; Brannan et al., 1990; Poirier et al., 1991) . The transcript has been shown to suppress the tumorigenicity of one human cancer cell line and retard the growth rate of another (Hao et al., 1993) , suggesting a possible growth suppressive role in vivo. Zgf-2 is a polypeptide mitogen which is transcriptionally regulated by three different promoters in the mouse (Rotwein and Hall, 1990) , giving rise to a variety of transcripts. Zgf-2 and HI9 are situated on the same chromosome, only 90kb apart in mice (Zemel et al., 1992) , and show striking similarities in their spatial and temporal expression patterns during embryonic and foetal development, both in mouse and in humans (DeChiara et al., 1991; Poirier et al., 1991; . The two genes are expressed from opposite l Corresponding author, Tel.: +46 18 182660; Fax: +46 18 182683. parental alleles, with the paternal allele of Zgf-2 being expressed while the maternal allele of HZ9 is expressed (Bartolomei et al., 1991; DeChiara et al., 1991) . The paternal chromosome shows marked methylation of the HI9 gene over most of its coding region and a closed chromatin conformation (Bartolomei et al., 1993; Ferguson-Smith et al., 1993) , while the Zgf-2 gene and the two enhancers downstream of the HI9 gene are in an open chromatin conformation on both chromosomes (Sasaki et al., 1992; Bartolomei et al., 1993; ) . It has therefore been suggested that the enhancers downstream of HZ9 may control expression of both genes where interaction with the closer HZ9 promoter would be blocked by methylation on the paternal chromosome, allowing the more distant Zgf-2 promoter to engage the enhancers (Bartolomei et al., 1993) . This is known as the enhancer competition model. A simpler proposal has also been made, namely that Zgf-2 and HZ9 may share an imprinting signal only, without necessarily competing for enhancer elements (Sasaki et al., 1992; Brandeis et al., 1993; Ferguson-Smith et al., 1993 (DeChiara et al., 1991; Riccio, 1994) gave us an opportunity to test these hypotheses.
The choroid plexus is a villous structure which projects mushroom-shaped bodies into each cerebral ventricle and is the main source of cerebrospinal fluid (Davson, 1967; Netsky and Shuangshoti, 1975) . Each mushroom body has an epithelium and an inner stromal part filled with blood vessels. The epithelium consists of modified ependyma, a cuboidal cell layer which lines the ventricles. The leptomeninges are the innermost pair of membranes surrounding the brain and consist of the arachnoid mater, which varies considerably in thickness and the monocellular pia mater (Davson, 1967) . We show here that HZ9 is expressed in the choroid plexus and leptomeninges in a pattern which overlaps that of Z&2 and that H19 is monoallelically expressed from the maternal ailele in these tissues. We discuss the implications of these findings for the enhancer competition and common imprint models of regulation of gene expression at the Igf2lH19 locus.
Results

In situ hybridization
In situ hybridization was performed to see if HZ9 was expressed in the choroid plexus and leptomeninges and, if so, where. To achieve the best possible morphological resolution for our analyses, we first paraffin embedded and sectioned an embryo and performed in situ analysis on the sections; then, when a good signal was achieved, the embryo was deparaffmised and prepared for scanning electron microscopy (S.E.M.). Fig. 1A shows a low-powered S.E.M. view of the saggitally-sectioned embryo, revealing the cranial region with the choroid plexus in the fourth ventricle marked. Fig. 1 B is a higher magnification, showing the surface and interior of the choroid plexus immediately adjacent to the section shown in Fig. 1C and D. High expression of HZ9 in the pia mater, in the more condensed outer layer of the arachnoid mater underlying the dura mater and in the stromal part of the choroid plexus can be seen (Fig. 1C) . The less dense layers of the arachnoid mater give a weaker signal. Fig. 1D is a light field view of the same section for comparison.
Since the choroid plexus is a highly vascularised tissue, it was of interest to see if HZ9 was expressed in the blood vessels. Fig. 1E shows a large blood vessel containing immature blood cells (arrow): comparing this to Fig. lC , it can be seen that there is no HZ9 signal in the blood cells or endothelium (note the absence of signal from the endothelium towards the outside of the choroid plexus). The epithelium of the choroid plexus, con- sisting of modified ependyma, may show some weak signal, but it is hard to exclude spill-over effects from the stromal signal here. There was no expression in the ependyma itself, which lines the ventricular cavities. Analysis of all the sections from one 16-day post coitum foetal brain showed no difference in H19 expression in different regions of the choroid plexus or leptomeninges (data not shown).
In situ hybridization using Zgf-2 and HI9 probes in parallel on adjacent sections showed that the two genes have very similar expression patterns in the choroid plexus and leptomeninges (Fig. 2) . One apparent difference in their expression patterns is that Zgf-2 appears to be expressed at equal levels in the epithelium of the choroid plexus and the stromal stalk, consistent with earlier reports, while HZ9 is strongly expressed only in the stroma of this tissue. Although many cells must be divided between the two adjacent sections, expression is uniform for both genes in the stromal part of the choroid plexus and in the leptomeninges. This uniform expression of Z&2 and HI9 was seen for all the slides in a series of adjacent sections through the leptomeninges and choroid plexus, comprising a large, continuous area of these tissues. This suggests that most, if not all, of the cells examined are coexpressing the two genes.
RNAse protection on HZ9 and Zgf-2 in the ckoroid plexus and leptomeninges
To analyse the allelic expression of H19, we isolated choroid plexus and leptomeninges from interspecific mouse crosses -the identity of the tissues was confirmed by examining the brain region before and after microdissection using S.E.M. An RNAse protection was carried out on RNA extractions using an HZ9 probe covering the polymorphic region from the 3 ' end of exon 3 to the middle of exon 5 (Fig. 3) . This probe protects a major band of 450 bp in M. m. domesticus and gives bands at about 240 bp and 210 bp in M. m. musculus. In both isolated leptomeninges and choroid plexus individually and in the choroid plexus/leptomeninges as a whole, expression is solely from the mother's allele. The very low-level expression we find in some neural tissues has been seen before. HZ9 appears to be expressed at quite a high level in the choroid plexus/leptomeninges, as can be seen by comparing the signal in these lanes to those in the liver sample lanes. The variations of intensity seen between the different samples of leptomeninges, choroid plexus and leptomeningeslchoroid plexus are due to the difficulty of quantifying the very small amounts of RNA extracted from each tissue sample.
RNAse protection was also carried out using Zgf-2 and HZ9 probes simultaneously to assess the ratio of expression of the two genes in various tissues. The Zgf-2 probe protects fragments of around 100 bp allowing separation of the two signals. Fig. 4 shows the result of one such experiment. The ratio of HI9 to Zaf-2 expression in placenta, muscle, liver and leptomeninges/choroid plexus can be seen to be very similar. Analysis by densitometric scanning gave a ratio of H19: Zgf-2 expression of 1.56 f 0.56 for the different organs assessed, with the average ratio in the choroid plexusfleptomeninges samples being 1.48 f 0.6, and 1.67 f 0.41 in the other organs examined .
Discussion
The mechanism underlying biallelic expression of Zgf-2 in the choroid plexus and leptomeninges !s not known. Both Zgf-2 and HZ9 have been found to be biallelically expressed in apparently normal preimplantation conceptuses, suggesting that the monoallelic expression of these genes in most tissues is established during postimplantation development by a repression of the maternal and paternal alleles, respectively (Latham et al., 1994, M.A. Surani, personal communication) . It is possible that the cellular mechanism to recognize imprints is lacking in the choroid plexus and leptomeninges. However, since we show here that the HZ9 gene imprint is manifested in these tissues, a general loss of functional imprinting there is not likely.
The enhancer competition model proposed for the regulation of expression of the HI9 and Zgf-2 genes (Bartolomei et al., 1993) suggests that only Zgf-2 or HZ9 can be expressed from a given chromosome, but not both. Under the common imprint model (Sasaki et al., 1992; Brandeis et al., 1993; Ferguson-Smith et al., 1993) , absence of the imprint or a failure to interpret it might allow expression of both alleles of both genes simultaneously. It is interesting to note that the biallelic expression of the HI9 and Zgf-2 genes in preimplantation mouse conceptuses (Latham et al., 1994, M.A. Surani, personal communication) is consistent with the common imprint but not the enhancer competition model. Our results strongly suggest that bialleleic expression of Zgf-2 and monoallelic expression of HZ9 can occur in the same cell in the choroid plexus and leptomeninges, which seems incompatible with either of these models. Efstratiadis has proposed a modification of the enhancer competition model (Efstratiadis, 1994) , wherein attachment of the Zgf2-H19 intergenic region to a nuclear scaffold on the maternal chromosome occurs, insulating the maternal Zgf-2 gene's promoters from interacting with the enhancers downstream of H19. This is considered necessary to prevent some significant interactions between the enhancers and both the Zgf-2 and HZ9 promoters on the maternal chromosome. Imprinting of the scaffold attachment site on the paternal chromosome prevents scaffold attachment and allows interactions between the enhancers downstream of the HI9 gene and the Zgf-2 promoters. Activation of the closer HZ9 promoter on this chromosome is prevented by its methylation. The advantage of this modified model over the original is that expression of both HZ9 and Zgf-2 from the maternal chromosome in the choroid plexus/leptomeninges could be explained by the absence of the protein responsible for mediating the scaffold attachment in these tissues (Efstratiadis, 1994) .
H19-Dom
We have earlier examined the expression patterns of ZGF-2 and HI9 in human choroid plexus and leptomeninges . ZGF-2 was found to be biallelically expressed in these tissues in a pattern very similar to that seen in the mouse tissues, but we could detect no H19 expression in any of the embryonic stages examined, which were comparable to the mouse stages examined here. H19's transcriptional silence in the human choroid plexus and leptomeninges could be due to methylation of the maternal HZ9 promoter in this tissue or to the absence of a vital transcription factor for HI9 in the human choroid plexusfleptomeninges. It is also possible that the expression of the Zgf-2 and HZ9 genes could be independently regulated, both regarding imprinting and spatiotemporal expression patterns. The similarity of their expression patterns could be explained by the presence of binding sites for the same tissuespecific transcription factors in their promoters. The physical proximity of the two genes may reflect a tendency for the genome to organise genes with this unusual form of regulation in clusters (Kitsberg et al., 1993) . The Mash and Ins2 genes upstream of Zgf-2 have recently been shown to be imprinted too (Giddings, 1994) , while there appears to be a cluster of imprinted genes at the Prader-Willi/Angelman syndrome locus (Nicholls, 1994; owelik et al., 1992) .
Greater characterisation of the elements required for the imprinting and correct transcriptional control of the Zgf-2 and HZ9 genes is necessary to determine if their transcription is in any way co-ordinated.
Experimental Fhcedures
Animals
Mice of the subspecies M. m. domesticus (NMRI strain) were mated with M. m. musculus to generate interspecific crosses. Foetuses were dissected out between days 14 and 18 of gestation.
In situ hybridization
Foetuses for in situ hybridization (14 and 16 day p.c.) were fixed in Camoy's fixative (60% ethanol, 30% chloroform and 10% acetic acid) for 4 h, then paraffin embedded and 4 pm sections taken. The sections was pretreated as previously described (Ohlsson et al., 1989) , except that sections were treated for 4 min in a 4% paraformaldehyde solution in PBS before and after Proteinase K treatment (for 5 min at room temperature). For HZ9, a 756-bp probe was labelled with 35S-UTP. For Zgf-2, a 223-bp PCR product corresponding to exon 4 (containing the translational start site) inserted in pBluescript KS(+) was used (kindly provided by Dr. Rashmi Kothary). The plasmid was linearized with EcoRI and transcribed with T7 polymerase in the presence of 35S-UTP. Hybridization was performed at 56°C overnight and the slides washed as previously described (Ohlsson et al., 1989) . The sections were covered with Kodak NTB emulsion and exposed for l-3 days. After development, the tissues were stained with haemotoxylin/eosin. The sections were not allowed to dry out at any stage during the protocol.
Scanning electron microscopy
Brains were fixed in Kamovskys fixative (1.5% paraformaldehyde and 1.5% glutaraldehyde in 0.1 M phosphate buffer, pH 7.4, freshly made) overnight, posttixed for 1 h in 1% 0~04, dehydrated in an ethanol series and critical point dried in liquid CO2 at 82 Atm. and 32°C. The specimens were sputter-coated with a gold/palladium mix in a Jeol sputtercoater and viewed in a JEOL-35 scanning electron microscope (SEM) at 15 KV. One foetus which had been paraffin embedded was prepared for S.E.M. by deparaffinising the sample in 56°C xylene, rehydrating in a descending alcohol series, postfixing in 1% 0~04 and then treating as the fresh tissue above.
Microdissection of choroid plexus and leptomeninges and preparation of RNA
Foetuses of interspecific crosses (17 day pc.) were microdissected in ice-cold phosphate-buffered saline under a L&z stereo microscope. The brain with attached leptomeninges (pia mater and arachnoidea) was dissected away from the skull -the dura mater remained attached to the braincase. The leptomeninges were peeled off the brain together with the attached choroid plexus, easily discriminated by its high degree of vascularisation and reddish colour. Isolated tissues were snap-frozen in liquid nitrogen and kept at -135°C. To ascertain that the right tissues had been isolated, brains at various stages of microdissection were fixed and visual&d by scanning electron microscopy. RNA was then prepared from the frozen samples (Chomczynski and Sacchi, 1987) .
RNAse protection analysis
Probes were as for in situ above, except labelled with 32P-UTP. The RNAse protection analyses of HZ9 expression were performed using 400 000 countslmin of probe (specific activity 92 Ci/mmol) annealed at 45"C, overnight to 0.5 rg of total cellular RNA from the indicated tissues, using the hybridization solution of the RNAse protection kit (Ambion). Excess probe was removed by RNAse degradation according to the manufacturer's protocol and the samples were analysed on a 6% acrylamide sequencing gel. The experiment was repeated twice with identical results. Simultaneous analysis of Zgf-2 and Hi9 was carried out by adding both probes to the RNA to be analysed, conditions as for HZ9 above. The ratio of expression levels was assessed by densitometric scanning of the autoradiographs using the Microscale TM/TC image analysis system (Digithurst Ltd).
